免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

FDA PMA

人工瓣膜,二尖瓣,經皮植入

PMA 核准號:P240042 · 2026-08-31

決定日期2026-08-31
PMA 編號P240042
產品代碼NPU
器械分類3 類
醫療專科U
諮詢委員會履歷

器材摘要

Prosthesis, mitral valve, percutaneously delivered is the device name listed in this FDA 510(k) record. The listed applicant is ABBOTT MEDICAL. It received FDA 510(k) clearance on 2026-08-31. The device is classified under product code NPU. It was reviewed by the CV advisory panel.

常見問題

What is the Prosthesis, mitral valve, percutaneously delivered?

Prosthesis, mitral valve, percutaneously delivered is a medical device that received FDA 510(k) clearance on 2026-08-31. The listed applicant is ABBOTT MEDICAL.

When did Prosthesis, mitral valve, percutaneously delivered receive FDA 510(k) clearance?

The clearance date for Prosthesis, mitral valve, percutaneously delivered can be found in the official FDA records.

誰是Prosthesis、二尖瓣、經皮植入的登記申請人?

The FDA 510(k) record lists ABBOTT MEDICAL as the applicant. This does not by itself establish the device manufacturer.

FDA產品代碼為Prosthesis、二尖瓣、經皮植入的代碼是什麼?

FDA產品代碼對於經皮植入的置換心臟瓣膜為NPU。

相關臨床試驗

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

官方來源

在 FDA 資料庫中查看 →

資料來源為 FDA Open API。如需最新且權威的資訊,請始終參閱官方記錄。

↑